SARS-CoV-2 Spike S1 Protéines
(SARS-CoV-2 Spike S1)
attaches the virion to the cell membrane by interacting with host receptor, initiating the infection (By similarity). Binding to human ACE2 receptor and internalization of the virus into the endosomes of the host cell induces conformational changes in the Spike glycoprotein (PubMed:32142651, PubMed:32075877, PubMed:32155444). Uses also human TMPRSS2 for priming in human lung cells which is an essential step for viral entry (PubMed:32142651). Proteolysis by cathepsin CTSL may unmask the fusion peptide of S2 and activate membranes fusion within endosomes.
Filtrer les résultats:
109 Résultats
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Cellules d'insectes
Recombinant
WB, EIA
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Cellules d'insectes
Recombinant
> 85 % by SDS-PAGE
ELISA, WB
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 95 % by SDS - PAGE
SDS, AcA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 90 % as determined by reducing SDS-PAGE.
ELISA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 85 % as determined by reducing SDS-PAGE.
ELISA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Baculovirus infected Insect Cells
Recombinant
> 90 % as determined by reducing SDS-PAGE.
ELISA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 90 % as determined by reducing SDS-PAGE.
ELISA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 85 % as determined by reducing SDS-PAGE.
ELISA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 90 % as determined by reducing SDS-PAGE.
ELISA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 90 % as determined by reducing SDS-PAGE.
ELISA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
ELISA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: HEK-293 Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
ELISA
Active
Origine: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Delta
Hôte: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
1 reference
Origine: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Omicron
Hôte: HEK-293 Cells
Recombinant
> 95% as determined by SDS-PAGE.
SDS
1 image
Origine: SARS Coronavirus-2 (SARS-CoV-2)
Hôte: Escherichia coli (E. coli)
Recombinant
>95 %
Origine: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Omicron
Hôte: HEK-293 Cells
Recombinant
95,00 %
Origine: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Delta
Hôte: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
Dernières publications pour nos SARS-CoV-2 Spike S1 Protéines
: "Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's disease." dans: Brain, behavior, and immunity, Vol. 109, pp. 251-268, (2023) (PubMed).
: "Point-of-care (POC) SARS-CoV-2 antigen detection using functionalized aerosol jet-printed organic electrochemical transistors (OECTs)." dans: Nanoscale, Vol. 15, Issue 11, pp. 5476-5485, (2023) (PubMed).
: "Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection." dans: Stroke, Vol. 52, Issue 1, pp. 260-270, (2021) (PubMed).
: "Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 5, (2021) (PubMed).
: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." dans: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).
: "Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization "Hotspots" in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction." dans: Journal of the American Society for Mass Spectrometry, (2021) (PubMed).
: "Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum." dans: ACS infectious diseases, (2021) (PubMed).
: "Delayed production of neutralizing antibodies correlates with fatal COVID-19. ..." dans: Nature medicine, (2021) (PubMed).
: "Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. ..." dans: Cell reports. Medicine, pp. 100288, (2021) (PubMed).
: "A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes. ..." dans: Nature communications, Vol. 12, Issue 1, pp. 2623, (2021) (PubMed).
: "Point-of-care (POC) SARS-CoV-2 antigen detection using functionalized aerosol jet-printed organic electrochemical transistors (OECTs)." dans: Nanoscale, Vol. 15, Issue 11, pp. 5476-5485, (2023) (PubMed).
: "Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection." dans: Stroke, Vol. 52, Issue 1, pp. 260-270, (2021) (PubMed).
: "Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 5, (2021) (PubMed).
: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." dans: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).
: "Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization "Hotspots" in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction." dans: Journal of the American Society for Mass Spectrometry, (2021) (PubMed).
: "Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum." dans: ACS infectious diseases, (2021) (PubMed).
: "Delayed production of neutralizing antibodies correlates with fatal COVID-19. ..." dans: Nature medicine, (2021) (PubMed).
: "Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. ..." dans: Cell reports. Medicine, pp. 100288, (2021) (PubMed).
: "A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes. ..." dans: Nature communications, Vol. 12, Issue 1, pp. 2623, (2021) (PubMed).
Pseudonymes pour SARS-CoV-2 Spike S1 Protéines
Surface Glycoprotein (S) ProtéinesE2 Protéines
Avez-vous cherché autre chose?
- SARS-CoV-2 Spike Protéines
- SARS-CoV-2 Papain-Like Protease Protéines
- SARS-CoV-2 Nucleocapsid Protéines
- SARS-CoV-2 NSP5 (3CL-Pro) Protéines
- SARS-CoV-2 Non-Structural Protein 7 Protéines
- SARS-CoV Spike Protéines
- SARS-Coronavirus Nucleocapsid Protein Protéines
- SARS-Coronavirus Membrane Protein Protéines
- SARNP Protéines
- SARM1 Protéines
- SARDH Protéines
- Sarcolemma Associated Protein Protéines
- Sarcalumenin Protéines
- SAR1B Protéines
- SAR1A Protéines
- SAPS2 Protéines
- SAPS1 Protéines
- SAP30BP Protéines
- SAP30-Like Protéines
- SAP30 Protéines
- SARS-CoV-2 Spike S2 Protéines
- SARS2 Protéines
- SART1 Protéines
- SART3 Protéines
- SASH1 Protéines
- SASH3 Protéines
- SAT1 Protéines
- SAT2 Protéines
- SATB1 Protéines
- SATB2 Protéines
- SAV1 Protéines
- SBDS Protéines
- SBEM Protéines
- SBK1 Protéines
- SBNO1 Protéines
- SC4MOL Protéines
- SC5DL Protéines
- SCAMP1 Protéines
- SCAMP3 Protéines
- SCAND1 Protéines
Vous êtes ici:
